A phase II study of α-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma - Concepedia

Concepedia

Publication | Closed Access

A phase II study of α-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma

74

Citations

13

References

1986

Year

Frank L. Meyskens, Edwin M. Kingsley, Theodore A. Glattke, Lois J. Loescher, A Booth

Investigational New Drugs

MedicineMelanomaPharmacologyMetastatic MelanomaPhase Ii StudyDermatologyOncologyCancer ResearchSkin Cancer

References

	Year	Citations

Page 1